FOXO3 and hepatocellular carcinoma: It has been revealed that doxorubicin-induced autophagy of HCC cells is facilitated by a decreased rate of miR-223 expression, targeting FOXO3a and so reduces the doxorubicin sensitivity of HCC cells.